Company Analysis

Onconetix, Inc. (ONCO)

Nasdaq: ONCO · Pharmaceutical Preparations · Cincinnati, OH · filing with the SEC since 2019
Grade3.3
◀ Past 2.8● Present 2.4▶ Future 4.5
2 est.

Who runs Onconetix, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
White David Allan
Chief Executive Officer. First filing Mar 2026, latest Mar 27, 2026, 0 filings in all.
Officers reporting now
1
of 7 people with a filing in the last fifteen months
Directors reporting now
6
22 people on the record since 2022
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
White David AllanChief Executive OfficerMar 2026Mar 27, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Dorf SammydirectorMar 2026Mar 27, 2026none
Romano SarahdirectorDec 2025Dec 12, 2025none
Meier ThomasdirectorFeb 2024Aug 19, 2025none
Oakley Andrew JohndirectorMar 2025Aug 19, 2025none
Ramdeen Timothy R.directorJan 2023Aug 19, 2025none
Tarsh SimondirectorAug 2022Aug 19, 2025none
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Hrt Financial LP10% ownerApr 2026Apr 22, 20263 · $100,000
Altos Venture AG10% ownerSep 2024Jul 16, 2025none
Earlier names on the record17, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ONCO · research, not advice